Author Archives: Jason Carr
Analysts Offer Insights on Services Companies: and Experian (Other OTC: EXPGF)
There’s a lot to be optimistic about in the Services sector as 1 analysts just weighed in on and Experian (EXPGF – Research Report) with bullish sentiments. Experian (EXPGF) In a report issued on July 16, Paul Sullivan from Barclays
H.C. Wainwright Thinks Cocrystal Pharma’s Stock is Going to Recover
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Cocrystal Pharma (COCP – Research Report), with a price target of $4.00. The company’s shares closed last Monday at $1.15, close to its 52-week low
Analysts Offer Insights on Healthcare Companies: Minerva Neurosciences (NASDAQ: NERV), Angion Biomedica (NASDAQ: ANGN) and DBV Technologies SA – American (NASDAQ: DBVT)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Minerva Neurosciences (NERV – Research Report), Angion Biomedica (ANGN – Research Report) and DBV Technologies SA – American (DBVT – Research Report)
Goldman Sachs Reaffirms Their Buy Rating on EasyJet (EJTTF)
In a report issued on July 20, Patrick Creuset from Goldman Sachs maintained a Buy rating on EasyJet (EJTTF – Research Report), with a price target of £11.50. The company’s shares closed last Monday at $12.10. According to TipRanks.com, Creuset
Barrington Believes Superior Industries International (NYSE: SUP) Still Has Room to Grow
Barrington analyst Gary Prestopino maintained a Buy rating on Superior Industries International (SUP – Research Report) today and set a price target of $12.50. The company’s shares closed last Friday at $8.50, close to its 52-week high of $9.72. According
Analysts Offer Insights on Technology Companies: Global Payments (NYSE: GPN) and Lyft (NASDAQ: LYFT)
Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Global Payments (GPN – Research Report) and Lyft (LYFT – Research Report). Global Payments (GPN) Rosenblatt Securities analyst Sean Horgan maintained a Buy
